# Formation Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/formation-bio

- Industry: Biotechnology
- Headquarters: New York, US
- Website: www.formation.bio
- Total disclosed funding: $605M
- Latest round: Series D (May 21, 2024)
- Investors on record: 15

## About

Established in 2016 and based in New York, US, Formation Bio, Inc. operates as a developer of drug medicine using artificial intelligence.

## Funding rounds

- Series D, May 21, 2024, $372M — Hong Shan, Andreessen Horowitz, SV Angel, Thrive Capital, Sanofi, Emerson Collective, FPV Ventures
- Series C, Sep 30, 2021, $156M — Hong Shan, Spark Capital, ArrowMark Partners, Felicis Ventures, Thrive Capital, Casdin Capital, Sound Ventures, Dragoneer Investment Group, Section 32
- Series B, Oct 15, 2018, $70M — Hong Shan, Spark Capital, Felicis Ventures, Thrive Capital, Sound Ventures, TQ Ventures
- Series A, Aug 31, 2017, $7M — Hong Shan, Thrive Capital

## Investors

- Hong Shan — Series A, Series B, Series C, Series D
- Thrive Capital (https://capitalatlas.ai/funds/thrive-capital) — Series A, Series B, Series C, Series D
- Spark Capital — Series B, Series C
- Felicis Ventures (https://capitalatlas.ai/funds/felicis-ventures) — Series B, Series C
- Sound Ventures (https://capitalatlas.ai/funds/sound-ventures) — Series B, Series C
- TQ Ventures (https://capitalatlas.ai/funds/tq-ventures) — Series B
- ArrowMark Partners — Series C
- Casdin Capital (https://capitalatlas.ai/funds/casdin-capital) — Series C
- Dragoneer Investment Group (https://capitalatlas.ai/funds/dragoneer-investment-group) — Series C
- Section 32 (https://capitalatlas.ai/funds/section-32) — Series C
- Andreessen Horowitz (https://capitalatlas.ai/funds/andreessen-horowitz) — Series D
- SV Angel (https://capitalatlas.ai/funds/sv-angel) — Series D
- Sanofi — Series D
- Emerson Collective — Series D
- FPV Ventures (https://capitalatlas.ai/funds/fpv-ventures) — Series D